Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Rosetta Genomics's Average Total Inventories for the quarter that ended in Jun. 2017 was $0.00 Mil. Rosetta Genomics's Revenue for the
three
months ended in Jun. 2017 was $0.87 Mil.
Rosetta Genomics's Inventory-to-Revenue for the quarter that ended in Jun. 2017 was 0.00.
Rosetta Genomics's Inventory-to-Revenue for the quarter that ended in Jun. 2017
stayed the same
from Dec. 2016 (0.00) to Dec. 2016 (0.00)
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Rosetta Genomics's Days Inventory for the
three
months ended in Jun. 2017 was 0.00.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Rosetta Genomics Inventory-to-Revenue Historical Data
The historical data trend for Rosetta Genomics's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Rosetta Genomics's Inventory-to-Revenue
For the Diagnostics & Research subindustry, Rosetta Genomics's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rosetta Genomics's Inventory-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Rosetta Genomics's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Rosetta Genomics's Inventory-to-Revenue falls into.
Rosetta Genomics Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Rosetta Genomics's Inventory-to-Revenue for the fiscal year that ended in Dec. 2016 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Rosetta Genomics's Days Inventory for the
three
months ended in Jun. 2017 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rosetta Genomics Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Rosetta Genomics's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Rosetta Genomics (Rosetta Genomics) Business Description
Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ROSGQ has been successfully added to your 